Baduanjin for ischemic heart failure with mildly reduced/preserved ejection fraction (BEAR Trial): A randomized controlled trial

Abstract

Aim: While Baduanjin, a traditional Chinese mind-body exercise, has shown potential health benefits, its efficacy in improving outcomes for heart failure patients with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) has not been well documented. We aimed to investigate the adjunctive impact of Baduanjin on exercise capacity and quality of life for HFmrEF/HFpEF.

Methods: Patients with HFmrEF/HFpEF were enrolled in this multicenter randomized clinical trial. All participants were randomized to conventional cardiac rehabilitation with or without an additional 12-week Baduanjin exercise. The primary endpoint was the distance covered in a 6-min walk test (6MWD), while key secondary outcomes included quality of life measured by the Minnesota Living with Heart Failure Questionnaire (MLHFQ) and cardiopulmonary function including anaerobic threshold (VO₂ AT).

Results: A total of 120 patients were enrolled, and 109 completed all session and tests. The mean age of the 120 patients was 60.5 years (SD, 9.21 years), and 23 (19.2%) were women. The Baduanjin group exhibited a 6.14% improvement in 6MWD compared to a 1.32% improvement in the control group (median improvement, 25.0 vs. 5.0 m; p < 0.001) at 12th week. The VO₂ AT increased by 25.87% in the Baduanjin group versus 3.94% in the control group (p < 0.001). Quality of life also significantly improved in the Baduanjin group as indicated by MLHFQ score changes (–16.8% vs. –3.99%; p < 0.001).

Conclusions: Adding Baduanjin to exercise-based cardiac rehabilitation for patients with ischemic HFmrEF or HFpEF are generally safe and could provide significant improvements in exercise capacity and quality of life.

Keywords

Baduanjin / cardiac rehabilitation / clinical trial / heart failure / traditional Chinese exercise

References

[1] HeidenreichPA,AlbertNM, AllenLA, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6(3),606–619.

[2] TsaoCW,AdayAW, AlmarzooqZI, et al. Heart Disease and Stroke Statistics-2022 Update: a report from the American Heart Association. Circulation. 2022;145(8),e153–e639.

[3] MetraM,Teerlink JR. Heart failure. Lancet (London, England). 2017;390(10106),1981–1995.

[4] SeverinoP,D’Amato A,PucciM, et al. Ischemic heart disease and heart failure: role of coronary ion channels. Int J Mol Sci. 2020;21(9),3167.

[5] SachdevV,SharmaK, KeteyianSJ, et al. Supervised exercise training for chronic heart failure with preserved ejection fraction: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2023;147(16),e699–e715.

[6] BorlaugBA. Evaluation and management of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2020;17(9),559–573.

[7] PiepoliMF,HoesAW, AgewallS, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29),2315–2381.

[8] YancyCW,JessupM, BozkurtB, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62(16),e147–e239.

[9] ThomasRJ,BaladyG, BankaG, et al. 2018 ACC/AHA Clinical performance and quality measures for cardiac rehabilitation: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol. 2018;71(16),1814–1837.

[10] ParkLG,Schopfer DW,ZhangN,ShenH,WhooleyMA. Participation in cardiac rehabilitation among patients with heart failure. J Card Fail. 2017;23(5),427–431.

[11] LavieCJ,PackQR, LevineGN. Expanding traditional cardiac rehabilitation in the 21st century. J Am Coll Cardiol. 2020;75(13),1562–1564.

[12] KohTC. Baduanjin—an ancient Chinese exercise. Am J Chin Med. 1982;10(1-4),14–21.

[13] WangXQ,PiYL, ChenPJ, et al. Traditional Chinese exercise for cardiovascular diseases: systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc. 2016;5(3),e002562.

[14] ChenBL,GuoJB, LiuMS, et al. Effect of traditional Chinese exercise on gait and balance for stroke: a Systematic Review and Meta-Analysis. PLoS One. 2015;10(8),e0135932.

[15] XiongX,WangP, LiS,ZhangY, LiX. Effect of Baduanjin exercise for hypertension: a systematic review and meta-analysis of randomized controlled trials. Maturitas. 2015;80(4),370–378.

[16] ChanJS,HoRT, ChungKF, et al. Qigong exercise alleviates fatigue, anxiety, and depressive symptoms, improves sleep quality, and shortens sleep latency in persons with chronic fatigue syndrome-like illness. Evid Based Complement Alternat Med. 2014;2014:106048.

[17] ZouL,YeungA, QuanX, et al. Mindfulness-based baduanjin exercise for depression and anxiety in people with physical or mental illnesses: a systematic review and meta-analysis. Int J Environ Res Public Health. 2018;15(2),321.

[18] ChenX,MarroneG, OlsonTP, et al. Intensity level and cardiorespiratory responses to Baduanjin exercise in patients with chronic heart failure. ESC Heart Fail. 2020;7(6),3782–3791.

[19] ChenX,JiangW, SalazarM, et al. Traditional Baduanjin exercise through the eyes of patients with chronic heart failure: a qualitative content analysis study. Front Cardiovasc Med. 2022;9:1049036.

[20] YuM,LiS, LiS,LiJ, XuH,ChenK. Baduanjin exercise for patients with ischemic heart failure on phase-II cardiac rehabilitation (BEAR trial): study protocol for a prospective randomized controlled trial. Trials. 2018;19(1),381.

[21] WangC,SchmidCH, RonesR, et al. A randomized trial of Tai Chi for fibromyalgia. N Engl J Med. 2010;363(8),743–754.

[22] HaskellWL,LeeIM, PateRR, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation. 2007;116(9),1081–1093.

[23] AgnewN. Preoperative cardiopulmonary exercise testing. Continuing Education in Anaesthesia Critical Care & Pain. 2010;10(2),33–37.

[24] ValimV,Oliveira LM,SudaAL, et al. Peak oxygen uptake and ventilatory anaerobic threshold in fibromyalgia. The Journal of rheumatology. 2002;29(2),353–357.

[25] RectorTS,CohnJN. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. American heart journal. 1992;124(4),1017–1025.

[26] XiongXH,DengX. The clinical observation of Baduanjin for chronic heart failure with CHD. Modern Medicine Journal of China. 2016;18(5),55–56. (In Chinese).

[27] ChenDM,YuWC, HungHF,Tsai JC,WuHY,ChiouAF. The effects of Baduanjin exercise on fatigue and quality of life in patients with heart failure: a randomized controlled trial. Eur J Cardiovasc Nurs. 2018;17(5),456–466.

[28] MaC,ZhouW, JiaY,TangQ. Effects of home-based Baduanjin combined with elastic band exercise in patients with chronic heart failure. Eur J Cardiovasc Nurs. 2022;21(6),587–596.

[29] ChenX,JiangW, OlsonTP, et al. Feasibility and preliminary effects of the BESMILE-HF program on chronic heart failure patients: a pilot randomized controlled trial. Front Cardiovasc Med. 2021;8:715207.

[30] MaoS,ZhangX, ChenM, et al. Beneficial effects of Baduanjin exercise on left ventricular remodelling in patients after acute myocardial infarction: an exploratory clinical trial and proteomic analysis. Cardiovasc Drug Ther. 2021;35(1),21–32.

[31] ForceERST,PalangeP, WardSA, et al. Recommendations on the use of exercise testing in clinical practice. Eur Respir J. 2007;29(1),185–209.

[32] LangCC,KarlinP, HaytheJ,Lim TK,ManciniDM. Peak cardiac power output, measured noninvasively, is a powerful predictor of outcome in chronic heart failure. Circ Heart Fail. 2009;2(1),33–38.

[33] KeteyianSJ,PatelM, KrausWE, et al. Variables measured during cardiopulmonary exercise testing as predictors of mortality in chronic systolic heart failure. J Am Coll Cardiol. 2016;67(7),780–789.

[34] CarlisleJ,SwartM. Mid-term survival after abdominal aortic aneurysm surgery predicted by cardiopulmonary exercise testing. Br J Surg. 2007;94(8),966–969.

[35] BoutronI,MoherD, AltmanDG,Schulz KF,RavaudP,GroupC. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med. 2008;148(4),295–309.

RIGHTS & PERMISSIONS

2024 The Author(s). Journal of Evidence-Based Medicine published by Chinese Cochrane Center, West China Hospital of Sichuan University and John Wiley & Sons Australia, Ltd.